中国实用儿科杂志

• 论著 • 上一篇    下一篇

血清肠型脂肪酸结合蛋白联合血清淀粉样蛋白A诊断重症新生儿坏死性小肠结肠炎应用价值研究

  

  1. 广东省妇幼保健院 a 新生儿科; b 保健部, 广东  广州  511442
  • 出版日期:2017-11-06 发布日期:2017-11-09

Value of serum intestinal fatty acid binding protein and serum amyloid A in the diagnosis of severe necrotizing enterocolitis in the newborn

  1. *Department of Neonatology,Guangdong Women and Children’s Hospital,Guangzhou  511442,China
  • Online:2017-11-06 Published:2017-11-09

摘要:

目的    探讨血清肠型脂肪酸结合蛋白(I-FABP)和血清淀粉样蛋白A(SAA)在诊断重症新生儿坏死性小肠结肠炎(NEC)的应用价值。方法 2014年10月至2015年10月在广东省妇幼保健院确诊为NEC的56例早产儿为病例组,其中Ⅰ期患儿26例,Ⅱ、Ⅲ期患儿30例;同期确诊为非消化系统疾病的30例患儿为对照组。采用酶联免疫吸附法(ELISA)检测各组患儿血清I-FABP和SAA水平。采用受试者工作特征曲线(ROC)对I-FABP和SAA诊断重症NEC进行评估。结果 NEC Ⅱ、Ⅲ期组血清I-FABP水平和SAA水平均显著高于NECⅠ期组和对照组(P<0.05);I-FABP血清标志物ROC曲线下面积(AUC)为0.80(95%CI:0.69~0.92),最佳截点值为21.8 μg/L,该截点值下诊断重症NEC的敏感度为70.0%,特异度为81.0%。SAA血清标志物ROC曲线下面积(AUC)为0.76(95%CI:0.63~0.89),最佳截点值为1657.8 μg/L,该截点值下诊断重症NEC的敏感度为67.0%,特异度为85.0%。结论 血清I-FABP和SAA可作为诊断NEC病情严重程度的参考指标。

关键词: 血清肠型脂肪酸结合蛋白, 血清淀粉样蛋白A, 新生儿, 坏死性小肠结肠炎

Abstract:

Objective To investigate the value of serum intestinal fatty acid binding protein(I-FABP) and serum amyloid A(SAA) in the diagnosis of necrotizing enterocolitis(NEC)in the newborn. Methods Fifty-six preterm infants with a confirmed diagnosis of NEC from October 2014 to October 2015 were recruited as case group(stageⅠ:26 cases;stageⅡ/Ⅲ:30 cases). Thirty children diagnosed with non-digestive diseases in the same period were recruited as the control group. Serum levels of I-FABP and SAA were determined by enzyme-linked immunosorbent assay.The diagnostic value of I-FABP and SAA for severe NEC was assessed using the receiver operating characteristic(ROC)curve. Results StageⅡ/Ⅲ cases in the case group had significantly higher serum I-FABP levels and SAA levels than the control group and StageⅠcases(P<0.05). The area under the ROC curve for serum I-FABP was 0.80(95%CI:0.69-0.92),with the optimal cut-off point of 21.8 μg/L. Under this cut-off point,the sensitivity and specificity were 70.0%and 81.0%,respectively. The area under the ROC curve for SAA was 0.76(95%CI:0.63-0.89),with the optimal cut-off point of 1657.8 μg/L. Under this cut-off point,the sensitivity and specificity were 67.0% and 80.0%,respectively. Conclusion In newborn infants with NEC,serum I-FABP and SAA l can be used as biomarkers for the diagnosis of severe NEC.

Key words: intestinal fatty acidbinding protein, serum amyloid A, newborn infant, necrotizing enterocolitis